Related Experiment Video
Updated: Jun 27, 2026
11:49
Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
[Elective lymph node dissections--still a standard in cancer surgery?].
1Institut für Med. Informationsverarbeitung, Biometrie und Epidemiologie (IBE) der Ludwig-Maximilians-Universität, München. hoe@ibe.med.uni-muenchen.de
Zentralblatt Fur Chirurgie
|December 19, 2008
Summary
Radical lymph node dissection in tumor surgery may no longer be standard. Evidence suggests lymph node status is a marker, not a cause, of distant metastases, questioning the necessity of routine dissection.
Area of Science:
- Oncology
- Surgical Oncology
- Cancer Metastasis
Context:
- Elective radical dissection of regional lymph nodes has been a standard surgical procedure for over a century.
- Current practices are being re-evaluated based on evolving understanding of cancer metastasis.
Purpose:
- To critically assess the continued relevance of standard lymph node dissection in tumor surgery.
- To determine if current lymph node dissection protocols align with the biological understanding of metastatic spread.
Summary:
- Lymph node status, while a prognostic factor, does not appear to be a causal factor in distant metastases.
- The number of positive lymph nodes may serve as a marker rather than a direct cause of disease progression.
- Local recurrences and distant metastases, rather than lymph node positivity itself, significantly impact patient survival.
Impact:
- Findings suggest a potential shift away from routine lymph node dissection towards more selective approaches.
- Reducing lymph node dissection in cases where it doesn't influence treatment decisions could be a biologically logical consequence.
- This re-evaluation may lead to revised surgical guidelines and improved patient outcomes by minimizing unnecessary procedures.
